DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Pharmaceuticals & Biotech
Updated 5h ago
ADVENT logo

Advent Pharma Ltd.DSE:ADVENT Stock Report

Market Cap ৳1.3b
Updated 5h ago
Share Price
n/a
1Y-14.6%
7D-4.3%
1D3.1%
Portfolio Value
​
View

Advent Pharma Ltd.

DSE:ADVENT Stock Report

Market Cap: ৳1.3b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Advent Pharma (ADVENT) Stock Overview

A pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. More details

ADVENT fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends1/6

Risk Analysis

Earnings have declined by 14.5% per year over past 5 years

Does not have meaningful revenue (BDT458M)

Does not have a meaningful market cap (BDT1B)


ADVENT Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW445,595 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
445,595 investors already sharing narratives
৳
Current Price
৳13.5039.9% overvalued intrinsic discount
%/yr
Decrease
Increase
PastFuture0606m2016201920222025202620282031Revenue ৳456.6mEarnings ৳47.9m
Advanced
View all narratives

Advent Pharma Ltd. Competitors

Silco Pharmaceuticals

Symbol: DSE:SILCOPHL
Market cap: ৳1.7b

Orion Infusion

Symbol: DSE:ORIONINFU
Market cap: ৳3.6b

Techno Drugs

Symbol: DSE:TECHNODRUG
Market cap: ৳5.3b

Navana Pharmaceuticals

Symbol: DSE:NAVANAPHAR
Market cap: ৳6.6b

Price History & Performance

Summary of share price highs, lows and changes for Advent Pharma
Historical stock prices
Current Share Price৳13.50
52 Week High৳17.10
52 Week Low৳11.50
Beta0.30
1 Month Change-14.01%
3 Month Change-12.90%
1 Year Change-14.56%
3 Year Change-41.30%
5 Year Change-45.79%
Change since IPO-62.13%

Recent News & Updates

Recent updates

Shareholder Returns

ADVENTBD PharmaceuticalsBD Market
7D-4.3%-1.4%-1.0%
1Y-14.6%-3.1%-7.2%

Return vs Industry: ADVENT underperformed the BD Pharmaceuticals industry which returned -4.2% over the past year.

Return vs Market: ADVENT underperformed the BD Market which returned -8.1% over the past year.

Price Volatility

Is ADVENT's price volatile compared to industry and market?
ADVENT volatility
ADVENT Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement3.7%
Market Average Movement4.7%
10% most volatile stocks in BD Market7.2%
10% least volatile stocks in BD Market2.3%

Stable Share Price: ADVENT has not had significant price volatility in the past 3 months compared to the BD market.

Volatility Over Time: ADVENT's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2007317Faria Alamwww.adventpharmabd.com

Advent Pharma Ltd., a pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. The company offers poultry, aquaculture, and cattle products. It provides its products in powder, bolus, and liquid dosage forms.

Advent Pharma Ltd. Fundamentals Summary

How do Advent Pharma's earnings and revenue compare to its market cap?
ADVENT fundamental statistics
Market cap৳1.26b
Earnings (TTM)৳48.03m
Revenue (TTM)৳458.15m
26.2x
P/E Ratio
2.7x
P/S Ratio

Is ADVENT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ADVENT income statement (TTM)
Revenue৳458.15m
Cost of Revenue৳319.10m
Gross Profit৳139.05m
Other Expenses৳91.02m
Earnings৳48.03m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)0.52
Gross Margin30.35%
Net Profit Margin10.48%
Debt/Equity Ratio4.9%

How did ADVENT perform over the long term?

See historical performance and comparison

Dividends

0.4%
Current Dividend Yield
7%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/15 04:29
End of Day Share Price 2026/09/15 00:00
Earnings2026/03/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Advent Pharma Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide